Syndax PharmaceuticalsvsThermo Fisher Scientific

SNDX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SNDX

Syndax Pharmaceuticals, Inc.

$9.13

Value $805M

-3.39%
SNDX's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Syndax Pharmaceuticals (SNDX) has a market value of $805M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, SNDX moved -45.1% and TMO +19.9%. Dividend yield: SNDX none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SNDX$805M

    TMO$257B

    TMO is 319 times SNDX

  • Revenue, 12 months

    SNDX$289M

    TMO$47.4B

    TMO is 164 times SNDX

  • Net income, 12 months

    SNDX-$209M

    TMO$7.1B

  • Operating margin

    SNDX-61.7%

    TMO17.9%

    79.6 points apart

  • ROIC

    SNDX-25.4%

    TMO8.2%

    33.5 points apart

  • P/E

    SNDX–

    TMO36.3

  • Dividend yield

    SNDX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    SNDX-49.0%

    TMO+10.9%

    59.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SNDX-49.0%

TMO+10.9%

5010015020222023202420252026
Returns by period
PeriodSNDXWith dividendsTMOWith dividends
1 year since November 14, 2025-45.1%Price -45.1%+19.9%Price +19.5%
3 years since November 16, 2023-38.4%-14.9% a yearPrice -38.4%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-49.0%-12.6% a yearPrice -49.0%+10.9%+2.1% a yearPrice +9.3%
10 years since November 16, 2016-8.2%-0.9% a yearPrice -8.2%+375.7%+16.9% a yearPrice +362.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SNDXSyndax PharmaceuticalsTMOThermo Fisher Scientific

Valuation

SNDXTMO
Valuation
Price$9.13$691.33
Market value$805M$257B
Enterprise value (EV)$972M$292B
P/E–36.3
P/E, 5-year median–32.7
P/B–4.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

SNDXTMO
Results and growth
Revenue, 12 months$289M$47.4B
Net income, 12 months-$209M$7.1B
Free cash flow, 12 months-$323M$7.6B
Earnings per share, 12 months-$2.36$18.96
Revenue growth, year on year627.8%3.9%
Revenue growth a year, past+157.7%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

SNDXTMO
Margins and returns on capital
Gross margin––
Operating margin-61.7%17.9%
Net margin-72.4%14.9%
ROIC-25.4%8.2%
ROE-477.0%13.4%

Balance sheet

SNDXTMO
Balance sheet
Cash$427M$6.1B
Total debt$595M$41.4B
Net debt / EBITDA–3.7
Interest cover-44,660.0×5.5×

Dividends and buybacks

SNDXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SNDX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Syndax Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 318.9 times Syndax Pharmaceuticals ($805M), at today's prices.

How did SNDX and TMO stock do over the last 10 years?

Since November 16, 2016, SNDX's price moved -8.2% and TMO's +362.5%. With dividends: SNDX -8.2% (-0.9% a year), TMO +375.7% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, SNDX or TMO?

The dividend yield at today's price is none for Syndax Pharmaceuticals and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Syndax Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -72.4% for Syndax Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin -61.7% and 17.9%. Revenue was $289M and $47.4B.

Which is the better investment, Syndax Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.